Zusammenfassung
Die orale Verabreichung von Bromelain in Form von 2 Ananase®-100-Tabletten an freiwillige Versuchspersonen verminderte bei diesen die Empfänglichkeit für die durch ADP induzierte Aggregation der Blutplättchen.
References
R. M. Heincke andW. A. Gortner, Econ. Bot.11, 225 (1957).
J. N. Moss, C. V. Frazier andG. S. Martin, Archs. int. Pharmacodyn. Thér.145, 166 (1963).
R. M. Heinicke, T. Ito, L. McCarthy andM. Yokoyama, Jap. Heart. J., in press.
H. Hayashi, M. Kono, M. Yoshinaga andM. Muto, Int. Symp. Como, Italy 1968. Excerpta med. int. Cong. Ser.188, 34 (1968).
M. Yamakido, N. Oishi andM. Yokoyama, Hawaii med. J.29, 1 (1970).
T. Sano, M. G. J. Boxer, L. A. Boxer andM. Yokoyama, Thromb. Diath. haemorrh.25, 524 (1971).
Author information
Authors and Affiliations
Additional information
This work was supported by the Honolulu Chamber of Commerce research grants.
About this article
Cite this article
Heinicke, R.M., van der Wal, L. & Yokoyama, M. Effect of bromelain (ananase®) on human platelet aggregation. Experientia 28, 844–845 (1972). https://doi.org/10.1007/BF01923166
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01923166